1. Home
  2. ARWR vs OXLC Comparison

ARWR vs OXLC Comparison

Compare ARWR & OXLC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ARWR
  • OXLC
  • Stock Information
  • Founded
  • ARWR 2003
  • OXLC 2010
  • Country
  • ARWR United States
  • OXLC United States
  • Employees
  • ARWR N/A
  • OXLC N/A
  • Industry
  • ARWR Biotechnology: Pharmaceutical Preparations
  • OXLC Investment Managers
  • Sector
  • ARWR Health Care
  • OXLC Finance
  • Exchange
  • ARWR Nasdaq
  • OXLC Nasdaq
  • Market Cap
  • ARWR 1.8B
  • OXLC N/A
  • IPO Year
  • ARWR 1993
  • OXLC N/A
  • Fundamental
  • Price
  • ARWR $12.97
  • OXLC $4.77
  • Analyst Decision
  • ARWR Buy
  • OXLC Strong Buy
  • Analyst Count
  • ARWR 11
  • OXLC 1
  • Target Price
  • ARWR $41.44
  • OXLC $6.00
  • AVG Volume (30 Days)
  • ARWR 1.7M
  • OXLC 1.9M
  • Earning Date
  • ARWR 05-12-2025
  • OXLC 11-01-2023
  • Dividend Yield
  • ARWR N/A
  • OXLC 18.86%
  • EPS Growth
  • ARWR N/A
  • OXLC N/A
  • EPS
  • ARWR N/A
  • OXLC 1.20
  • Revenue
  • ARWR $2,500,000.00
  • OXLC $130,145,365.00
  • Revenue This Year
  • ARWR $4,380.43
  • OXLC $136.15
  • Revenue Next Year
  • ARWR $64.24
  • OXLC $5.51
  • P/E Ratio
  • ARWR N/A
  • OXLC $4.24
  • Revenue Growth
  • ARWR N/A
  • OXLC N/A
  • 52 Week Low
  • ARWR $9.57
  • OXLC $4.41
  • 52 Week High
  • ARWR $30.41
  • OXLC $5.70
  • Technical
  • Relative Strength Index (RSI)
  • ARWR 53.31
  • OXLC 58.40
  • Support Level
  • ARWR $12.44
  • OXLC $4.69
  • Resistance Level
  • ARWR $14.97
  • OXLC $4.73
  • Average True Range (ATR)
  • ARWR 0.71
  • OXLC 0.07
  • MACD
  • ARWR 0.16
  • OXLC 0.03
  • Stochastic Oscillator
  • ARWR 61.36
  • OXLC 97.89

About ARWR Arrowhead Pharmaceuticals Inc.

Arrowhead Pharmaceuticals Inc is an American biotechnology company. Its main target is the development of medicine to treat diseases with a genetic origin, characterized by the overproduction of one or more proteins. Its medical solutions are aimed at the genes that trigger the diseases. Its portfolio includes drugs targeting cardiovascular, Cardiometabolic, Central Nervous System, Pulmonary, Liver, Muscular, and Complement Mediated Disease. It majority products are liver disease curable.

Share on Social Networks: